Tagged with UK

Jae-young Lee – CEO, Bukwang Pharmaceuticals
GSK’s Luke Miels Bets Bigger than Ever on M&A: Can Growth Outpace the Patent Cliff?
Hazel Jones – Chief Strategy Officer, Laverock Therapeutics
Priya Kishnani – Director, Division of Medical Genetics, Duke University School of Medicine
Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
Preparing for the UK’s New Clinical Trial Safety Rules
Melanie Ivarsson – Scientific Advisory Board Member, PhaseV
UK Clinical Research Regulation: A Collaborative Path to Modernization, Innovation, and Access
How UK–French Ambition Can Create Europe’s Silicon Valley
UK Pharma: Life Sciences Strategy on the Rocks; Sanofi Buys Vicebio; AstraZeneca Looks Stateside
UK: AstraZeneca Snags Cell Pioneer EsoBiotec; UK Pharma Awaits US-UK Trade Deal Outcome
UK Dismantles NHS England: Potential Public Health Disruptions without Obvious Solutions?
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here